Feed DSRLF
DS

DiaSorin S.p.A.

DSRLF · OTC

$86.00 +0.00% (+$0.00)
Market Cap 3.71B €
P/E Ratio 20.83x
Div. Yield 1.75%
ROE 11.73%

Bulios Fair Price

$45.73

46.8% downside

Current Price

$86

Undervalued Fair Value Overvalued

According to Bulios Fair Price, DSRLF is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
78 /100
Cheap
P/E 20.83x
EV/EBITDA 9.61x
P/S 2.13x
Growth
3 /100
Declining
EPS growth 13.56%
Rev. growth 4.26%
FCF growth 9.39%
Profitability
83 /100
Strong
Gross margin 64.48%
Net margin 10.21%
Op. margin 15.81%
Quality
49 /100
Average
ROIC 7.50%
ROE 11.73%
ROA 6.15%
Debt
74 /100
Low
Debt/Equity 0.67x
Current ratio 1.79x
Int. coverage 8.73x
Stability
90 /100
Stable
Beta 0.68x
Rev. volatility 10.26%
EPS volatility 25.41%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about DSRLF
Online

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Carlo Rosa

Employees

3,272

Headquarters

Saluggia

Upcoming events

05 NOV

Earnings

Upcoming earnings report

37d
12 MAR

Earnings

Upcoming earnings report

164d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.